InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Buckman Paul, 董事. Officer active across 5 companies, notably NEUROONE MEDICAL TECHNOLOGIES Corp. Cumulatively, 19 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €47k. History available since 2 June 2021. The latest transaction was disclosed on 3 April 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Buckman Paul
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
5,046 股Common StockSEC:0001215243-26-000005:0
41,929 股0Common StockSEC:0001215243-26-000004:0
2,180 股0Class A Common StockSEC:0001215243-26-000003:0
19,401 股@ US$2.4804100.0% 占其流量Common StockSEC:0001215243-26-000001:0
6,198 股Common StockSEC:0001641172-25-022245:0
27,778 股0Common StockSEC:0001215243-25-000001:0
27,778 股@ US$0.8063100.0% 占其流量Common StockSEC:0001215243-24-000001:0
52,593 股Common StockSEC:0001415889-23-016377:0
54,201 股0Common StockSEC:0001415889-23-009216:0
83,054 股0Class A Common StockSEC:0001140361-23-026971:0
31,250 股@ US$1.60100.0% 占其流量Common StockSEC:0001415889-23-005634:0
标准退出：2023年6月8日 (T+90)
20,576 股0Common StockSEC:0001215243-23-000001:0
12,788 股0Common StockSEC:0001415889-22-008659:0
29,240 股0Common StockSEC:0001215243-22-000001:0
6,049 股0Class A Common StockSEC:0001140361-22-020582:0
721 股0Class A Common StockSEC:0001209191-21-055888:0
3,000 股Common StockSEC:0001179110-21-007131:0
5,555 股0Common StockSEC:0001179110-21-007035:0
4,592 股0Common StockSEC:0001596771-21-000038:0
19 条申报中的 19 条
About Buckman Paul
BUCKMAN PAUL is Administrateur and appears in 19 filings in total. In the recent filings held, they cover the period from 2021-06-04 to 2026-06-29, with total buys of EUR 47238 and no total sells, and the modal transaction nature is Attribution. They are linked to NEUROONE MEDICAL TECHNOLOGIES Corp, Miromatrix Medical Inc., SHOULDER INNOVATIONS, INC., Helius Medical Technologies, INC., and Solana Co.
